spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 27 Mar 2009
Teva Announces Approval and Launch of Generic Topamax Tablets
Biopharmaceuticals Neurology FDA Generics
 HSMN NewsFeed - 27 Mar 2009
Zydus Pharmaceuticals (USA) Inc. Announces FDA Final Approval for the Generic Version of Topamax(R) Tablets
Biopharmaceuticals Neurology FDA Generics
 HSMN NewsFeed - 27 Mar 2009
Nabriva Therapeutics Appoints Dr David Chiswell as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2009
Sagent Pharmaceuticals Announces U.S. FDA Approval of Azithromycin for Injection
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Mar 2009
MacroGenics Appoints New Vice President of Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2009
Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
Biopharmaceuticals Endocrinology Cardiology
 HSMN NewsFeed - 26 Mar 2009
Neuraltus Pharmaceuticals Raises $17 Million Series A Funding
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 26 Mar 2009
Roche Completes Tender Offer for Genentech
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Mar 2009
Transcept Pharmaceuticals Appoints Joseph T. Kennedy as General Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2009
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 24 Mar 2009
Perrigo Announces FDA Approval for Sulfacetamide Sodium Topical Suspension USP, 10% (Lotion)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 24 Mar 2009
FABLYN Approved in Europe for the Treatment of Osteoporosis
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 24 Mar 2009
Biodel to Submit New Drug Application for VIAject to FDA
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 24 Mar 2009
FDA Approves New Indication for Wyeth's TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Mar 2009
Ischemix Appoints Robert DuFresne as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2009
Celsion Receives Orphan Drug Designation for ThermoDox to Treat Primary Liver Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 24 Mar 2009
Epiphany Biosciences Initiates Program to Assess Valomaciclovir (EPB-348) as Adjunctive Therapy in Multiple Sclerosis (MS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Mar 2009
Oxygen Biotherapeutics, Inc. Establishes Warfighter Division
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2009
Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Mar 2009
Endo Pharmaceuticals Completes Acquisition of Indevus Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Mar 2009
Watson Announces a Nationwide Voluntary Recall of Propafenone HCL Tablets Due to Oversized Tablets
Biopharmaceuticals Generics Product Recall
 HSMN NewsFeed - 23 Mar 2009
Pfizer's Oncology Business Unit Appoints Senior Executive to Head U.S. Region
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 23 Mar 2009
Neuromed Announces Exalgo(TM) (hydromorphone HCl) Extended-Release Tablets (CII) Meets Primary Efficacy Endpoint in Pivotal Phase 3 Trial
Biopharmaceuticals Pain Management
 HSMN NewsFeed - 23 Mar 2009
Morphotek(R), Inc. and Eisai Corporation of North America Announce FDA Special Protocol Assessment (SPA) for Phase III Trial Evaluating Farletuzumab in Relapsed Ovarian Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Mar 2009
U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'RESUS' Clinical Trial in Trauma Patients in the Out-of-Hospital Setting
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Mar 2009
FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Mar 2009
Merck Serono Launches Strategic Venture Capital Fund
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Mar 2009
Skyepharma PLC Announces Regulatory Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 20 Mar 2009
Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 20 Mar 2009
Shire Files Lawsuit Against Mylan for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 20 Mar 2009
Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA(R) (methylphenidate transdermal system) patches announced
Biopharmaceuticals Product Recall
 HSMN NewsFeed - 19 Mar 2009
OSI Pharmaceuticals Files Patent Infringement Lawsuits Against Teva Pharmaceuticals USA and Mylan Pharmaceuticals
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Mar 2009
NeurogesX' Qutenza(TM) (NGX-4010) Receives Positive Committee Recommendation in European Union
Biopharmaceuticals Pain Management Regulatory
 HSMN NewsFeed - 19 Mar 2009
Genzyme Receives Positive Opinion for European Approval of Renvela for Patients with Kidney Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Mar 2009
European CHMP Adopts Negative Opinion on Aztreonam Lysine
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Mar 2009
Endo Pharmaceuticals Announces Successful Completion of Tender Offer for Indevus Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Mar 2009
Cortex Pharmaceuticals Announces Corporate Restructuring and Workforce Reduction
Biopharmaceuticals
 HSMN NewsFeed - 19 Mar 2009
Alvine Pharmaceuticals Appoints Dr. Daniel C. Adelman, M.D. as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2009
Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Mar 2009
Oragenics, Inc. Announces Management Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Mar 2009
OSI Pharmaceuticals Submits Supplemental New Drug Application to the FDA for Tarceva as a First-Line Maintenance Therapy in Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Mar 2009
FDA Advisory Committee Recommends Approval of Multaq(R) (dronedarone)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 18 Mar 2009
Gleevec(R) substantially reduces risk of cancer returning in patients with life-threatening gastrointestinal stromal tumors (GIST), The Lancet reports
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Mar 2009
Provenance Biopharmaceuticals Corp. Announces License Agreement with Merck Serono for the Development and Commercialization of Novel Immunocytokine for the Treatment of Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 18 Mar 2009
FIRMAGON(R) (Degarelix) is Launched in Europe for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Mar 2009
Medivation Receives FDA Permission to Initiate Phase 3 Trial of MDV3100 in Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Mar 2009
Sopherion Therapeutics Announces Completion of Enrollment in Phase III Study of Myocet in Metastatic Breast Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Mar 2009
Nanobac Pharmaceuticals and Eureka Genomics Agree to Terms for Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Mar 2009
Perrigo and Partner Cobrek Confirms Filing for Generic Version of Evoclin(R) and Announcement of Lawsuit by Stiefel
Biopharmaceuticals Generics Litigation FDA
 HSMN NewsFeed - 17 Mar 2009
Oxygen Biotherapeutics, Inc. to Launch Product Line of Oxycyte(R) Gels for the Over-the-Counter Market
Devices Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2009
Cephalon Announces Positive Results From a Phase Two Study of NUVIGIL in Bipolar Depression
Biopharmaceuticals
 HSMN NewsFeed - 17 Mar 2009
Basilea's Toctino(R) receives marketing authorization in Austria
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 16 Mar 2009
MannKind Submits NDA for AFRESA for Treatment of Diabetes
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 16 Mar 2009
Shire Files Lawsuit Against Barr Laboratories for Infringement of FOSRENOL(R) (Lanthanum Carbonate) Patents
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 16 Mar 2009
Paul Chew Appointed to sanofi-aventis U.S. Chief Science Officer/Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Mar 2009
Data Presented at AAAAI Reinforce Baxter's Commitment to Making GAMMAGARD LIQUID Therapy More Convenient
Biopharmaceuticals
 HSMN NewsFeed - 16 Mar 2009
Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 16 Mar 2009
CytRx's Arimoclomol Demonstrates Statistically Significant Neurorestorative Results in a Preclinical Embolic Stroke Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Mar 2009
United Therapeutics Announces Probable Delay in Approval Timeline for Inhaled Treprostinil (Tyvaso)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 16 Mar 2009
Spectrum Pharmaceuticals Acquires 100% of ZEVALIN, an FDA-Approved, Proprietary, Biological Drug for Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 16 Mar 2009
Orexo's Edluar (Sublinox) Receives FDA Approval for the Treatment of Insomnia
Biopharmaceuticals FDA
 HSMN NewsFeed - 16 Mar 2009
Astellas to Terminate Offer for CV Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Mar 2009
Synta Restructures Organization to Focus on New Priorities
Biopharmaceuticals
 HSMN NewsFeed - 13 Mar 2009
DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Mar 2009
Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 12 Mar 2009
ULORIC(R) (febuxostat) 40-mg and 80-mg Tablets Now Available for the Chronic Management of Hyperuricemia in Patients with Gout
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2009
CV Therapeutics' Board of Directors Rejects Astellas' Tender Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 12 Mar 2009
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Mar 2009
Sutent Significantly Increases Progression Free Survival for Patients with Advanced Pancreatic Islet Cell Tumors, Study Stopped Early
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Mar 2009
Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor
Biopharmaceuticals Generics FDA HIV/AIDS
 HSMN NewsFeed - 12 Mar 2009
I-Flow Corporation Receives FDA Clearance for Stabilized Antimicrobial Wound Gel
Biopharmaceuticals Wound Care FDA
 HSMN NewsFeed - 12 Mar 2009
Ipsen: AZZALURE Approved in the UK for Aesthetic Use in the Treatment of Glabellar Lines
Biopharmaceuticals Regulatory Dermatology
 HSMN NewsFeed - 12 Mar 2009
Roche and Genentech Reach a Friendly Agreement to Combine the Two Organizations and Create a Leader in Healthcare Innovation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Mar 2009
Phase III Study of Rituxan in Lupus Nephritis Did Not Meet Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 11 Mar 2009
FDA Approves an Expanded Indication for Peginterferon-Based Combination Therapy for Patients With Chronic Hepatitis C
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2009
Molecular Insight Receives Special Protocol Assessment Approval From FDA for Phase 2 Trial of Azedra(TM), a Radiotherapeutic to Treat Neuroendocrine Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Mar 2009
European Commission Approves ReFacto AF(TM) as a Variation to the Refacto(R) Marketing Authorisation
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Mar 2009
Calistoga Pharmaceuticals Announces Appointment of Clifford J. Stocks as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2009
CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
Biopharmaceuticals FDA
 HSMN NewsFeed - 11 Mar 2009
Shire Announces Launch of FOSRENOL(R) in Japan
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 11 Mar 2009
Basilea's Toctino(R) Receives Marketing Authorization in Belgium and Luxemburg
Biopharmaceuticals Dermatology Regulatory
 HSMN NewsFeed - 10 Mar 2009
Tolerx Expands Phase 3 'DEFEND' Trial of Otelixizumab in Europe
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 10 Mar 2009
FDA Grants Orphan Drug Designation for EUR-1073
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 9 Mar 2009
Lilly Granted Temporary Restraining Order to Halt Launch of Generic Raloxifene
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 9 Mar 2009
ULURU Inc. Announces Senior Management Change
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2009
Teikoku Pharma USA and Eisai Co., Ltd. Announce Licensing Agreement for a New 7-Day Transdermal Formulation of Donepezil
Biopharmaceuticals Drug Delivery Neurology Licensing
 HSMN NewsFeed - 9 Mar 2009
IDM Pharma's MEPACT(R) (Mifamurtide, L-MTP-PE) Receives Approval in Europe for Treatment of Patients with Non-Metastatic, Resectable Osteosarcoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 Mar 2009
DiaMedica Appoints Stephen J. Waters as Interim Chief Scientific Officer
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 9 Mar 2009
Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C
Biopharmaceuticals
 HSMN NewsFeed - 9 Mar 2009
Merck and Schering-Plough to Merge
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Mar 2009
Victory Pharma Announces US$45 Million Equity Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Mar 2009
FDA Appeal Decision Indicates that Genasense(R) Approval in Chronic Lymphocytic Leukemia Will Require Additional Confirmatory Trial
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 7 Mar 2009
Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Mar 2009
Genentech Urges Shareholders to Take No Action With Respect to Revised Offer From Roche
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Mar 2009
Acanya(TM) Gel, a New Treatment for Moderate to Severe Acne, Launched by Coria Laboratories
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 6 Mar 2009
Sanofi-aventis and AEterna Zentaris Sign Agreement in the U.S.
Biopharmaceuticals Licensing Urology
 HSMN NewsFeed - 6 Mar 2009
AcelRx Pharmaceuticals Hires Mark Evashenk as Vice President of Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2009
BioForm Medical to Launch New 1.5cc RADIESSE(r) Volume Advantage Syringe and 0.8cc RADIESSE Moderate Fill Syringe; Announces Successful Results of RADIESSE Dermal Filler With Lidocaine Clinical Study
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 6 Mar 2009
AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
Biopharmaceuticals Licensing Urology
 HSMN NewsFeed - 5 Mar 2009
Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 5 Mar 2009
Pyratine XR(TM) Launches at 67th AAD Meeting, Offering Hope to 14 Million Rosacea Sufferers
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 5 Mar 2009
European Commission and United States Food and Drug Administration (FDA) Both Approve New Options for Patients With Certain Primary Brain Tumors
Biopharmaceuticals Oncology FDA Regulatory
 HSMN NewsFeed - 5 Mar 2009
EPIX Pharmaceuticals Appoints Elkan Gamzu, Ph.D., as Permanent CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Mar 2009
GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Mar 2009
Lilly's Anthony Murphy Announces Retirement
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Mar 2009
Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Mar 2009
FDA Accepts Investigational New Drug (IND) Application for Tigris Pharmaceutical's GGTI-2418
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Mar 2009
Savara Expands Board of Directors, Appoints Three New Members
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 3 Mar 2009
Bristol-Myers Squibb Announces Organizational Changes; Names Four to Company's Executive Committee
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2009
Bristol-Myers Squibb Names Andreotti President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2009
Mark J. Gabrielson Named Chief Executive Officer of Ore Pharmaceuticals
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Mar 2009
Pfizer and Bausch & Lomb to Co-Promote Products for the Treatment of Ophthalmic Conditions
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 3 Mar 2009
Pfizer Expands Portfolio of Generic Medicines in the U.S. and Europe Through Licensing Agreements with Aurobindo
Biopharmaceuticals Licensing
 HSMN NewsFeed - 2 Mar 2009
ImClone Systems and Bristol-Myers Squibb Update Status of First-Line Squamous Cell Carcinoma of the Head and Neck Supplemental Biologics Application for ERBITUX(R) in U.S.
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Mar 2009
Lilly Announces Leadership Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2009
BioMarin Appoints Dr. Henry J. Fuchs as Senior Vice President and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2009
Pearl Therapeutics Appoints Perry Karsen as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2009
Rockwell Medical Technologies, Inc. Appoints Richard Yocum, M.D. as VP of Drug Development and Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Mar 2009
Hi-Tech Pharmacal Acquires ECR Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Mar 2009
Orexo's AbstralTM Receives Two Further Large EU Market Approvals in France and Spain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 27 Feb 2009
Endo Pharmaceuticals Returns Product Rights to TRANSDUR(TM)-Sufentanil to DURECT
Biopharmaceuticals
 HSMN NewsFeed - 27 Feb 2009
EPIX Pharmaceuticals Announces Resignation of Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Feb 2009
Astellas Commences Tender Offer to Acquire All Outstanding Shares of CV Therapeutics for $16.00 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Feb 2009
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Feb 2009
Eiger BioPharmaceuticals Raises $7.1 Million 'A' Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Feb 2009
FDA Approves Genzyme's Synvisc-One for Osteoarthritis of the Knee
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Feb 2009
FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen
Biopharmaceuticals Drug Delivery Endocrinology FDA
 HSMN NewsFeed - 26 Feb 2009
The Medicines Company Completes Acquisition of Targanta Therapeutics Corporation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Feb 2009
Forest Laboratories, Inc. Provides Statement in Response to Complaint Filed by U.S. Government
Biopharmaceuticals
 HSMN NewsFeed - 25 Feb 2009
Aton Pharma Acquires U.S. TIMOPTIC(R)
Biopharmaceuticals Ophthalmology Acquisitions
 HSMN NewsFeed - 25 Feb 2009
ARCA biopharma Appoints Kathryn Falberg as Chief Financial Officer and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2009
Otsuka America Pharmaceutical, Inc. and Otsuka Pharmaceutical Development & Commercialization, Inc. Announce Restructuring Changes Aimed at Growing Otsuka's Pharmaceutical Business Worldwide
Biopharmaceuticals
 HSMN NewsFeed - 25 Feb 2009
Selecta Biosciences, Inc. Closes $15.1M Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 25 Feb 2009
Proteolix Announces the Appointment of John Scarlett, M.D., President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Feb 2009
Elan Announces Further Alignment of Resources as Part of On-Going Strategic Review Process
Biopharmaceuticals
 HSMN NewsFeed - 24 Feb 2009
Merck Serono and Ambrx Expand Collaboration Through ARX424 Multiple Sclerosis Drug Development Alliance
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Feb 2009
Pfizer Discontinues Development of Two Phase 3 Compounds
Biopharmaceuticals
 HSMN NewsFeed - 24 Feb 2009
Sopherion Therapeutics Announces Appointment of New Senior Executive Vice President for Clinical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Feb 2009
Heptares Secures GBP21 Million in Series A Fund Raising to Accelerate Development of Pipeline of Small Molecules Against High-Value GPCR Drug Targets
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Feb 2009
Basilea Pharmaceutica files claims against Johnson&Johnson over its handling of ceftobiprole (ZEFTERA(TM)/Zevtera(TM)) clinical studies
Biopharmaceuticals Litigation
 HSMN NewsFeed - 24 Feb 2009
CHMP delays European Commission decision process to approve ZEVTERA(TM)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Feb 2009
MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints
Biopharmaceuticals
 HSMN NewsFeed - 23 Feb 2009
Genentech Special Committee Rejects Roche's $86.50 Offer as Inadequate
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 23 Feb 2009
KAPIDEX(TM) (dexlansoprazole) delayed release capsules Now Available for the Treatment of GERD
Biopharmaceuticals
 HSMN NewsFeed - 23 Feb 2009
Nostrum Pharmaceuticals Obtains Worldwide Licensing Rights From IMTECH for Clinical Development of the Small Molecule Caerulomycin and Its Proprietary Derivatives for Their Novel Indication of Immunosuppression
Biopharmaceuticals Licensing
 HSMN NewsFeed - 23 Feb 2009
AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression
Biopharmaceuticals
 HSMN NewsFeed - 23 Feb 2009
Flamel Technologies Announces Appointment of Jeffery S. Vick as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 23 Feb 2009
European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI
Biopharmaceuticals Cardiology Regulatory
 HSMN NewsFeed - 23 Feb 2009
Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Feb 2009
Spectrum Pharmaceuticals Poised to Acquire 100% Interest in RIT Oncology LLC Joint Venture upon CTI's Fulfillment of Closing Conditions
Biopharmaceuticals Oncology Acquisitions
 HSMN NewsFeed - 23 Feb 2009
Bavarian Nordic Updates on Phase I/II Studies With Breast Cancer Vaccine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Feb 2009
Astellas Pharma Issues Statement Regarding CV Therapeutics Rejection of All-Cash Proposal
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 20 Feb 2009
UCB to divest Equasym(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 20 Feb 2009
Shire Announces Opening of Office in Japan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Feb 2009
Schering-Plough Submits Response to FDA for SAPHRIS(TM) (asenapine) in the Acute Treatment of Both Schizophrenia and Bipolar I Disorder
Biopharmaceuticals
 HSMN NewsFeed - 20 Feb 2009
Shire to Enter European ADHD Market With the Acquisition of EQUASYM(R) IR and XL
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 19 Feb 2009
CRESTOR Cuts Risk of Stroke by Nearly Half in JUPITER Study
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 19 Feb 2009
European Medicines Agency Recommends Suspension of Marketing Authorization for Raptiva(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 Feb 2009
European Commisssion Grants Ferring Pharmaceuticals Approval of FIRMAGON(R) (Degarelix) for Treatment of Prostate Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Feb 2009
Eisai and Bial Announce Partnership Agreement for the European Commercialisation of the Novel Once Daily Anti-Epileptic Zebinix(R)
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 19 Feb 2009
QRxPharma Initiates Second Comparative Study for MoxDuo(TM) IR Dual-Opioid(TM) Pain Therapy
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2009
AVI BioPharma Announces Treatment of First Patient in Systemic Clinical Trial of AVI-4658 for Treatment of Duchenne Muscular Dystrophy
Biopharmaceuticals
 HSMN NewsFeed - 19 Feb 2009
Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Feb 2009
Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Feb 2009
FDA Accepts Nuvo's Resubmission For Pennsaid(R)
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 18 Feb 2009
Gilead Receives Response From U.S. FDA on Company's Request for Formal Dispute Resolution for Aztreonam for Inhalation Solution
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 18 Feb 2009
NanoBio Corporation Raises $12 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Feb 2009
KYTHERA BIOPHARMACEUTICALS Secures Additional $10M
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 18 Feb 2009
Opsona Therapeutics Closes EUR18M Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Feb 2009
Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Feb 2009
Cipher receives tentative FDA approval for extended-release tramadol capsules
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 17 Feb 2009
Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
Biopharmaceuticals Licensing
 HSMN NewsFeed - 17 Feb 2009
Break-through Drug for Heart Failure in Dogs Now Available in the United States
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Feb 2009
GSK Initiates Phase III Programme for Novel Type 2 Diabetes Medication, Syncria(R) (albiglutide)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 17 Feb 2009
Sinobiomed Announces New Executive Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Feb 2009
Newly Published Menopause Study: 'Bioidentical' and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 17 Feb 2009
Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Feb 2009
Sirion Therapeutics Partners With Advanced Vision Research (TheraTears(R)) to Promote Products for Retinal and Meibomian Gland Health
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 16 Feb 2009
AlphaVax Announces New Vice President of Regulatory, Quality and Clinical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2009
FDA Approves ULORIC(R) (febuxostat) for the Chronic Management of Hyperuricemia in Patients with Gout
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Feb 2009
IMPACT Study Demonstrates That Longer Prophylactic Therapy With Valcyte(R) (Valganciclovir Hydrochloride Tablets) Increases Protection Against CMV - the Most Serious Viral Infection Affecting Transplant Patients
Biopharmaceuticals
 HSMN NewsFeed - 13 Feb 2009
ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
Biopharmaceuticals
 HSMN NewsFeed - 13 Feb 2009
Novogen to Focus on Oncology Program
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Feb 2009
Haemacure Restructures - Seeks Financing or Sale of the Company
Biopharmaceuticals Devices Surgery Wound Care
 HSMN NewsFeed - 12 Feb 2009
Alios BioPharma, Inc. Completes First Closing of Series A Financing With Commitment of $24 MM From 3 Top-Tier Investors
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Feb 2009
AVI BioPharma, Inc. Appoints Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Feb 2009
Otsuka America Pharmaceutical, Inc. Announces the Appointment of Mark Altmeyer as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Feb 2009
Results of First Interim Efficacy Analysis for Riquent Phase 3 ASPEN Trial: Continuation of the Trial is Futile
Biopharmaceuticals
 HSMN NewsFeed - 12 Feb 2009
La Jolla Pharmaceutical Company Announces Negative Results of Interim Efficacy Analysis for Riquent Phase 3 ASPEN Trial
Biopharmaceuticals
 HSMN NewsFeed - 12 Feb 2009
Insmed Sells Follow-on Biologics Platform to Merck & Co., Inc. for Gross Proceeds of $130 Million
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 12 Feb 2009
Merck & Co., Inc. Acquires Biologic Manufacturing Capabilities and Developmental Follow-on Biologics Portfolio from Insmed
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 11 Feb 2009
Oscient Pharmaceuticals Restructures Commercial Organization
Biopharmaceuticals
 HSMN NewsFeed - 11 Feb 2009
New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 11 Feb 2009
AspenBio Appoints Robert Caspari, M.D. as Chief Operating Officer and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2009
AspenBio Announces Management Team Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2009
Genocea Biosciences Names Jane Halpern Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2009
PREZISTA(R) Now Available for Pediatric Patients Six Years of Age and Older as part of HIV Combination Therapy
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 11 Feb 2009
Genta Submits Randomized Study of Tesetaxel in Patients with Advanced Gastric Cancer to FDA for Special Protocol Assessment
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Feb 2009
Jean-Pierre Lehner Appointed Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2009
Laurence Debroux Appointed Chief Strategic Officer (CSO)
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Feb 2009
HemCon Medical Technologies, Inc. Announces Further Successful Results from Live Nail Infection Anti-Fungal Study
Biopharmaceuticals
 HSMN NewsFeed - 10 Feb 2009
FDA Issues Complete Response Letter for RISPERDAL(R) CONSTA(R) for the Adjunctive Maintenance Treatment of Bipolar Disorder
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Feb 2009
Neoprobe Hires V.P. of Pharmaceutical Research & Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Feb 2009
Physicians Continue to Limit Sales Rep Access
Biopharmaceuticals Devices
 HSMN NewsFeed - 10 Feb 2009
Teva Announces Approval and Launch of Generic Imitrex(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Feb 2009
Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 10 Feb 2009
Enzon Announces IND Acceptance for Its Survivin Antagonist
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Feb 2009
Enzon Discontinues Further Development of rhMBL
Biopharmaceuticals
 HSMN NewsFeed - 10 Feb 2009
Dyax and Fovea Sign Development and Commercialization Agreement for DX-88 in Ophthalmic Indications
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 10 Feb 2009
FDA Approves Clinical Studies of a Novel Anti-Cancer Drug Developed by Italian Researchers
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Feb 2009
Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 9 Feb 2009
Genentech Urges Shareholders to Take No Action With Respect to Unsolicited Tender Offer From Roche
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Feb 2009
Roche Commences Tender Offer for Genentech for US$86.50 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Feb 2009
Sagent Pharmaceuticals Announces Expansion of Cefazolin Product Line to Include Cefazolin for Injection, USP in 500mg Single-Dose Vial
Biopharmaceuticals
 HSMN NewsFeed - 9 Feb 2009
ViroPharma Reports Results of Phase 3 Clinical Trial for Maribavir in Bone Marrow Transplant Patients
Biopharmaceuticals
 HSMN NewsFeed - 9 Feb 2009
Aerovance Appoints Babatunde A. Otulana, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Feb 2009
Shire Receives FOSRENOL Paragraph IV Notice Letters from Barr Laboratories and Mylan
Biopharmaceuticals Generics
 HSMN NewsFeed - 9 Feb 2009
MS Patients Treated with TYSABRI Remain Free of Disease Activity for Two Years, According to Data Published in the Lancet Neurology
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Feb 2009
deCODE Breakthrough in Thyroid Cancer May Enable More Targeted Risk Assessment and Earlier Intervention
Biopharmaceuticals Diagnostics Oncology
 HSMN NewsFeed - 6 Feb 2009
ROXRO Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 6 Feb 2009
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA Filings for Paliperidone Palmitate and INVEGA(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Feb 2009
Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV
Biopharmaceuticals Licensing HIV/AIDS
 HSMN NewsFeed - 5 Feb 2009
GlaxoSmithKline and Genmab Seek European Marketing Authorisation of Arzerra (Ofatumumab) in Advanced Stage Blood Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 5 Feb 2009
Immunomedics' hPAM4 Labeled With Yttrium-90 Receives Fast Track Designation From FDA for Therapy of Pancreatic Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 5 Feb 2009
Tibotec Submits Application to U.S. Food and Drug Administration Seeking Traditional Approval for INTELENCE(TM) (etravirine)
Biopharmaceuticals
 HSMN NewsFeed - 5 Feb 2009
Dr. Reddy's Announces Five ANDA Approvals and Generic Product Launches in the US Market
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 4 Feb 2009
FDA Advisory Committee Favors Approval of DX-88 for Acute Attacks of Hereditary Angioedema
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Feb 2009
Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 4 Feb 2009
COPAXONE(R) is Approved for Treatment of Patients with a First Clinical Event Suggestive of Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 4 Feb 2009
Peregrine Pharmaceuticals' Bavituximab Achieves Primary Endpoint in First Stage of Phase II Lung Cancer Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Feb 2009
Neurobiological Technologies Announces Appointment of William A. Fletcher as Acting CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2009
Abraxis BioScience Launches ABRAXANE in Germany
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Feb 2009
Pfizer's Sutent is Recommended as First-Line Treatment for Kidney Cancer Patients by British Health Agency
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Feb 2009
Prasugrel Receives Unanimous Approval Recommendation from FDA Advisory Committee
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 3 Feb 2009
FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Feb 2009
Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 3 Feb 2009
Warner Chilcott Announces Agreement to Acquire Topical Alprostadil Treatment for Erectile Dysfunction
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 3 Feb 2009
Cerenis Therapeutics In-Licenses Intellectual Property for New Treatment of Aortic Valve Stenosis
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 3 Feb 2009
King Pharmaceuticals Announces Corporate Restructuring to Reduce Operating Expenses
Biopharmaceuticals
 HSMN NewsFeed - 3 Feb 2009
Merck Serono's Safinamide Significantly Improved Motor Function in Patients With Advanced Parkinson's Disease in a Phase III Pivotal Trial
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Feb 2009
Hollis-Eden Pharmaceuticals Announces Cost-Cutting Measures to Focus Resources on Advancement of Ongoing Clinical Development Programs
Biopharmaceuticals
 HSMN NewsFeed - 2 Feb 2009
SCOLR Pharma, Inc. Announces Appointment of Bruce S. Morra, Ph.D., as President & CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2009
Dr. D. Gary Gilliland, Internationally-Recognized Physician and Researcher, Joins Merck Research Labs as Head of Oncology Research
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2009
Molecular Insight Pharmaceuticals Announces Board and Senior Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2009
pSivida Corp. Names Paul Ashton, Ph.D. President and Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 2 Feb 2009
Federal Trade Commission Files Complaint Against Par Pharmaceutical Over Court-Approved AndroGel(R) Litigation Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 2 Feb 2009
Transcept Pharmaceuticals, Inc. Completes Merger with Novacea, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Feb 2009
Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 2 Feb 2009
The Health Authorities of 15 European Countries Give a Collective Green Light to Azzalure For the Treatment of Glabellar Lines, Paving the Way for National Marketing Authorizations
Biopharmaceuticals Regulatory Dermatology
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!